Not all tests are created equal: Identifying C. diff in hospital labs
A study from the microbiology lab at the Lifespan hospitals has found that some lab tests are much more accurate in identifying Clostridium difficile Toxin (C. diff) infection (CDI), which causes diarrhea. The findings indicate that a molecular method detects up to 50 percent more cases of C. diff than other methods. While molecular technology is more expensive, it allows for more cases to be identified and assists in patient safety efforts within the hospital in terms of preventing hospital-acquired C. diff infections. The study is published online the July issue of the Journal of Molecular Diagnostics.
C. diff is a bacterium that produces toxins that cause diarrhea. A 2009 article in the American Journal of Infection Control reported an estimated 13 in every 1,000 hospital inpatients had C. diff -- 20 times more than previous estimates. In Rhode Island, that number is estimated to be closer to 29 per 1,000 patients, and is among the highest in the country. In her paper, lead author Kimberle Chapin, M.D., director of the microbiology lab at Lifespan, reports that across the country, C. diff results in 9,000 hospital deaths each year, along with 3,000 post-discharge deaths and 16,500 deaths in nursing homes. To prevent the spread of C. diff, it is critical that it be identified and both appropriate treatment and proper infection control methods be implemented to prevent the spread to others.
In Chapin's study, she compared five different assays used in the laboratory for identifying C. diff. Her labs at Rhode Island Hospital/Hasbro Children's Hospital, The Miriam Hospital and Newport Hospital perform 15,000 C. diff assays each year. The study evaluated the results of molecular versus non-molecular tests. Chapin says, "The molecular methods we tested detected between 35 and 54 percent more patients who were positive for C. diff than the non-molecular methods."
Chapin says these findings bring up concerns in the number of unconfirmed cases of C. diff in hospitals that are not using molecular methods. "Through the use of molecular testing in our lab, combined with astute physicians and nurses requesting the tests, we were able to detect 50 percent more patients than we did prior to using molecular methods. Knowing the non-molecular tests did not find as many cases lead to patient safety concerns and the drive to implement the new method," she says.
The principle affiliation of Chapin is Lifespan, a health system in Rhode Island, and direct financial and infrastructure support for this project was received through the Lifespan Office of Research Administration. The researcher also has an academic appointment at The Warren Alpert Medical School of Brown University. Chapin's lab is fully supported by the Lifespan health system.
Provided by Lifespan
- Study: Lesser-known bug a bigger hospital threat Mar 20, 2010 | not rated yet | 0
- What makes C-Diff superbug deadly? Mar 01, 2009 | not rated yet | 0
- Treatment sought for diarrhea strain Oct 13, 2006 | not rated yet | 0
- Is re-emerging superbug the next MRSA? Sep 15, 2008 | not rated yet | 0
- Scientists study emerging strains of superbug Clostridium difficile Feb 26, 2009 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Classical and Quantum Mechanics via Lie algebras
Apr 15, 2011 I'd like to open a discussion thread for version 2 of the draft of my book ''Classical and Quantum Mechanics via Lie algebras'', available online at http://lanl.arxiv.org/abs/0810.1019 , and for the...
- More from Physics Forums - Independent Research
More news stories
A new case of the deadly coronavirus has been detected in Saudi Arabia where 15 people have already died after contracting it, the health ministry announced on Saturday on its Internet website.
Diseases, Conditions, Syndromes 2 hours ago | not rated yet | 0
(HealthDay)—Few randomized clinical trials have been done to assess clinical prediction rules for patients with lower back pain, and the trials that have been done are of low quality and do not provide ...
Diseases, Conditions, Syndromes May 17, 2013 | not rated yet | 0 |
A new, highly sensitive blood test that quickly detects even the lowest levels of malaria parasites in the body could make a dramatic difference in efforts to tackle the disease in the UK and across the world, according to ...
Diseases, Conditions, Syndromes May 17, 2013 | not rated yet | 0
(AP)—The World Health Organization says a yellow fever booster vaccination given 10 years after the initial shot isn't necessary.
Diseases, Conditions, Syndromes May 17, 2013 | not rated yet | 0
An increasing number of U.S. children are experiencing gastrointestinal issues that require interventions to resolve, according to research presented at Digestive Disease Week (DDW).
5 hours ago | not rated yet | 0 |
The latest makeover to a massive psychiatric tome honored by some, reviled by others and even called the "Bible" of mental disorders is being released Saturday with a host of new changes.
2 hours ago | not rated yet | 0
Big names in medicine are set to give an upbeat assessment of the war on AIDS on Tuesday, 30 years after French researchers identified the virus that causes the disease.
13 hours ago | 5 / 5 (1) | 0
For combat veterans suffering from post-traumatic stress disorder, 'fear circuitry' in the brain never rests
Chronic trauma can inflict lasting damage to brain regions associated with fear and anxiety. Previous imaging studies of people with post-traumatic stress disorder, or PTSD, have shown that these brain regions can over-or ...
14 hours ago | 5 / 5 (1) | 0 |
A ground-breaking advance in colonoscopy technology signals the future of colorectal care, according to research presented today at Digestive Disease Week(DDW). Additional research focuses on optimizing the minimal withdrawal ...
5 hours ago | 5 / 5 (1) | 0
In 2008 researchers from the University of Southern Denmark showed that the drug thioridazine, which has previously been used to treat schizophrenia, is also a powerful weapon against antibiotic-resistant bacteria such as ...
23 hours ago | 3.7 / 5 (3) | 0 |